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periodontal diseases. The soft tissue infection caused by Aggregatibacter often is associated
with Actinomyces species. Beside, most Capnocytophaga infections are described in immuno-
compromised patients. We identified facial cellulitis caused by Capnocytophaga spp and
Aggregatibacter (Actinobacillus) actinomycetemcomitans in a 16-year-old immunocompetent
female.
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Bacteria of the genus Capnocytophaga and Actinobacillus
occur in normal oral flora and in the presence of
periodontal disease.1,2 These organisms can cause peri-
odontal infection, soft tissue abscess (often in associationished by Elsevier Taiwan LLC. All rights reserved.
Figure 2. Pathology of the mass, with fragments of necrotic
debris, neutrophil exudates, and aggregates of basophilic
clumps that resemble sulfur granules (Inset).
150 C.-J. Hsieh et al.with Actinomyces species), endocarditis, and systemic
infection. They are also associated with sepsis, usually in
immunocompromised patients. We identified facial cellu-
litis caused by Capnocytophaga spp and Aggregatibacter
actinomycetemcomitans (formerly in the genus Actino-
bacillus)3 in a 16-year-old immunocompetent female.
Case report
A 16-year-old female noted the development of a mild
tender left facial mass 1 month before presentation in our
facility, in July 2008 (Fig. 1). She noted that the size of the
mass increased slowly and was associated with increasing
local heat and erythema. She originally sought medical
attention and received an unknown antibiotic. In addition,
a dental clinic diagnosed caries, but no procedure was
performed. Thirty days after presentation, her symptoms
were unchanged and she was admitted. She gave no history
of tuberculosis, diabetes, or any other disease that might
affect immunological function.
Physical examination indicated that she was apyrexial
and had a 2  2 cm mass over the left mandibular area. The
mass was smooth, fluctuant, and fixed deeply with over-
lying cellulitis. The parotid and mandibular ducts were
normal, and no calculi were evident in the floor of her
mouth. A tuberculin skin test was negative.
Incision and drainage of the mass yielded debris and
a small amount of pus. A course of oral clarithromycin and
amikacin was administered 6 days after hospitalization, but
the mass was unchanged. A Gram stained film of the pus
indicated no visible organisms, and a Ziehl-Neelsen stain was
negative for acid fast bacilli. Pathology of the tissue indi-
cated fragments of necrotic debris, neutrophil exudates, and
aggregates of basophilic clumps that resembled sulfur gran-
ules (Fig. 2). A Giemsa stain indicated no bacilli and a Gram
stain indicated no Actinomycosis.
A bacterial culture was negative after 48 hours, but
indicated a light growth of Capnocytophaga species and
gram-negative bacilli after 9 days. Identification of Cap-
nocytophaga species was performed with the RAPID-ANA II
system (Innovative Diagnostic Systems, Inc., Norcross,
GA, USA). The gram-negative bacilli were identifiedFigure 1. Clinical photograph of the left mandibular mass,
about 2  2 cm.as Aggregatibacter actionmycetemcomitans, based on
conventional biochemical methods and confirmed by partial
16S rRNA sequence analysis [accession number M75039.1
(Aggregatibacter actinomycetemcomitans), identity 99%
(529/530)].3,4 A disc susceptibility test indicated that both
organisms were susceptible to amoxicillin/clavulanic acid,
aztreonam, cefuroxime, third-generation cephalosporins
(i.e. ceftazidime, ceftriaxone), piperacillin  tazobactam,
ertapenem, and ciprofloxacin, but that Capnocytophaga
spp was resistant to amikacin, cefazolin, and gentamicin.
Thus, 7 days after admission, the antibiotic was changed
to intravenously amoxicillin/clavulanic acid (3.6 g daily
divided into 3 doses) combined with oral clarithromycin
(500 mg twice a day). The patient’s symptoms improved
over the next 5 days. She was nearly asymptomatic and
discharged from our clinic.
Discussion
Anaerobic and microaerophilic bacteria that were previ-
ously considered harmless are now considered pathogenic.5
These organisms can cause severe infections, especially
after solid organ or hematopoietic stem cell transplantation
or if introduced into otherwise sterile sites, such as during
a surgical procedure. Bacteria of the genera Capnocyto-
phaga and Aggregatibacter can occur in normal oral flora
and in the presence of periodontal disease,1,2 often in
immunocompromised patients. However, Capnocytophaga
infections have more recently been reported in immu-
nocompetent patients.6 A actinomycetemcomitans is
a member of the HACEK group (Haemophilus aphrophilus,
Haemophilus paraphrophilus, A actinomycetemcomitans,
Cardiobacterium hominis, Eikenella corrodens, and King-
ella spp), and is one of the major agents of adult and
juvenile periodontitis.2 It may occur in combination with
Acetinomyces spp, in particular Actinomyces israelii,7 in
sulfur granules. We are unaware of any previous report
that has identified Capnocytophaga spp and A actino-
mycetemcomitans as pathogens responsible for facial
cellulitis in an immunocompetent patient.
Facial mass by A actinomycetemcomitans & Capnocytophaga 151A actinomycetemcomitans is a nonspore-forming, nonmo-
tile, small, fastidious gram-negative coccobacilli that cannot
growonMacConkey agar. It also grows slowly inbroth, possibly
leading to delays in identification. This species was first
described in 1912 byKlinger, and its classification has changed
many times. A actinomycetemcomitnas was identified as an
oral human microbe in the 1950s, and since 1962 has
been considered capable of causing serious infections, such
as periodontal disease, soft tissue abscess (often in
association with Actinomyces species), systemic disease, and
endocarditis.6,7 Because of its slow growth, serologic exami-
nation may be helpful for diagnosis. Significantly elevated
antibody titers occur during the active stage of infection, and
the titers decrease during convalescence. Serologic exami-
nationwas not performed inour patient, because this testwas
unavailable at our hospital.
Ampicillin or penicillin, often in conjunction with an
aminoglycoside, is often used to treat infection because
of A actinomycetemcomitans, but resistance to these
antibiotics is increasingly common. Cefazolin, cefotaxime,
cetriaxone, aminoglycosides, and chloramphenicol have
a high degree of in vitro activity against this species, so
should also be considered. Therapy should be guided by
clinical response and in vitro susceptibility testing.
The seven species in the genus Capnocytophaga are
gram-negative, fastidious, capnophilic rods with fusiform
morphology and gliding motility. Species of this genus are
present in the normal oral flora of humans (Capnocytophaga
ochracea, Capnocytophaga gingivalis, Capnocytophaga
sputigena) and mammals such as canines, cats, and
rodents (Capnocytophaga animorsus and Capnocytophaga
cynodegmi).
Capnocytophaga species are frequently isolated as part of
a polymicrobial flora and have been reported as causes of
localized infection, bacteremia, and sepsis in immunocom-
promised patients.6,8,9 Neutropenia and oral mucositis are
the most important risk factors predisposing to bloodstream
infection after an endogenous infection or a wound infection
from an animal bite or closed-fist injury.6 In immunocom-
petent hosts, Capnocytophaga species are occasionally
involved in localized, mostly polymicrobial infections with
other oral flora.8,9 Following an animal bite, human infection
is characterized by a necrotizing eschar.10 Alcoholics and
patients who have undergone splenectomy are particularly
predisposed to severe septicemia following an animal bite.
Isolation of Capnocytophaga requires careful collection
of specimens and appropriate processing. In addition,
suspicious material should be cultivated in a CO2-enriched
atmosphere. Capnocytophaga spp are usually susceptible to
broad-spectrum b-lactams, marcolides, doxycycline, and
fluoroquinolones, but are resistant to aminoglycosides and
colistin. b-Lactamase-positive isolates have been found,
and they were susceptible to combination therapy withb-lactamase inhibitors. Patients with septicemia generally
have a good prognosis if they are empirically treated early
with imipenem or a b-lactamase inhibitor combination for
several weeks.
Capnocytophaga spp and A (Actinobacillus) actino-
mycetemcomitans are unusual pathogens, but can cause
severe infections, mainly in immunocompromised hosts.
Recent reports showed that species in these genera can
also cause infections in immunocompetent hosts. This case
report and other recent studies emphasize the need for
appropriate culture techniques for these species, espe-
cially for lesions close to the oral cavity. In particular,
cultures must be followed for a week or more if Capnocy-
tophaga spp or Actinobacillus spp are to be detected.
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